| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.3 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.21 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |